“Overly prescriptive”, “onerous on pharmaceutical companies” and “disappointing”. These were just some of the words that the research-based drug industry used to describe its experience with the EU Paediatric Regulation in response to a consultation by the European Commission, which is due to publish a report on how the regulation is faring since it was introduced 10 years ago.
The Paediatric Regulation has helped improve the health of children over the past 10 years by stimulating the development of...







